August 18, 2008
Arno Therapeutics Announces Second Quarter 2008 Financial Results more »

August 14, 2008
Arno Therapeutics Announces Appointment of Brian Lenz, CPA as Chief Financial Officer more »

July 17, 2008
Arno Therapeutics Announces New Ticker Symbol more »

June 5, 2008
BioWorld Today - Arno Gets $18M Plus Market Access in Reverse Merger more »

June 4, 2008
Arno Therapeutics, Inc. Completes $18 Million Financing and Reverse Merger more »

Jan. 28, 2008
Arno Therapeutics Completes License Agreements for the Exclusive Rights to Novel, Targeted Cancer Compounds more »